MyMeds: A pilot study assessing the impact of technology in delivering personalised interventions to support patients to adhere to oral anti-diabetic medicatio
Not Applicable
Recruiting
- Conditions
- DiabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12616001305415
- Lead Sponsor
- Atlantis Healthcare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1026
Inclusion Criteria
Participants will be eligible to participate in this study if they have Type 2 diabetes for which they are prescribed oral medications only and are over 18. Participants who are prescribed insulin will be excluded from this study. Participants will be included in the study only if they have daily access to a mobile phone.
Exclusion Criteria
Cannot read English. No Access to a mobile phone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method